Abstract

A diverse antibody repertoire is essential for humoral immunity. Antibody diversification requires the introduction of deoxyuridine (dU) mutations within immunoglobulin genes to initiate somatic hypermutation (SHM) and class switch recombination (CSR). dUs are normally recognized and excised by the base excision repair (BER) protein uracil-DNA glycosylase 2 (UNG2). However, FAM72A downregulates UNG2 permitting dUs to persist and trigger SHM and CSR. How FAM72A promotes UNG2 degradation is unknown. Here, we show that FAM72A recruits a C-terminal to LisH (CTLH) E3 ligase complex to target UNG2 for proteasomal degradation. Deficiency in CTLH complex components result in elevated UNG2 and reduced SHM and CSR. Cryo-EM structural analysis reveals FAM72A directly binds to MKLN1 within the CTLH complex to recruit and ubiquitinate UNG2. Our study further suggests that FAM72A hijacks the CTLH complex to promote mutagenesis in cancer. These findings show that FAM72A is an E3 ligase substrate adaptor critical for humoral immunity and cancer development.

Antibody diversification relies on the intentional mutagenesis of immunoglobulin genes for adaptive immune responses. Here, the authors identified a CTLH E3 ubiquitin ligase complex that co-opts FAM72A to recruit and degrade the UNG2 base excision repair factor to permit mutagenesis.

Details

Title
FAM72A degrades UNG2 through the GID/CTLH complex to promote mutagenic repair during antibody maturation
Author
Barbulescu, Philip 1 ; Chana, Chetan K. 2 ; Wong, Matthew K. 1 ; Ben Makhlouf, Ines 3 ; Bruce, Jeffrey P. 4 ; Feng, Yuqing 1 ; Keszei, Alexander F. A. 4 ; Wong, Cassandra 5 ; Mohamad-Ramshan, Rukshana 6 ; McGary, Laura C. 5 ; Kashem, Mohammad A. 1 ; Ceccarelli, Derek F. 7   VIAFID ORCID Logo  ; Orlicky, Stephen 7 ; Fang, Yifei 1 ; Kuang, Huihui 8 ; Mazhab-Jafari, Mohammad 4 ; Pezo, Rossanna C. 9 ; Bhagwat, Ashok S. 6   VIAFID ORCID Logo  ; Pugh, Trevor J. 4   VIAFID ORCID Logo  ; Gingras, Anne-Claude 10   VIAFID ORCID Logo  ; Sicheri, Frank 11   VIAFID ORCID Logo  ; Martin, Alberto 1   VIAFID ORCID Logo 

 University of Toronto, Department of Immunology, Toronto, Canada (GRID:grid.17063.33) (ISNI:0000 0001 2157 2938) 
 University of Toronto, Department of Biochemistry, Toronto, Canada (GRID:grid.17063.33) (ISNI:0000 0001 2157 2938); Sinai Health System, Lunenfeld-Tanenbaum Research Institute, Toronto, Canada (GRID:grid.492573.e) (ISNI:0000 0004 6477 6457) 
 University of Toronto, Department of Molecular Genetics, Toronto, Canada (GRID:grid.17063.33) (ISNI:0000 0001 2157 2938) 
 University of Toronto, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada (GRID:grid.17063.33) (ISNI:0000 0001 2157 2938) 
 University of Toronto, Department of Biochemistry, Toronto, Canada (GRID:grid.17063.33) (ISNI:0000 0001 2157 2938); Wayne State University, Department of Chemistry, Detroit, USA (GRID:grid.254444.7) (ISNI:0000 0001 1456 7807) 
 Wayne State University, Department of Chemistry, Detroit, USA (GRID:grid.254444.7) (ISNI:0000 0001 1456 7807) 
 Sinai Health System, Lunenfeld-Tanenbaum Research Institute, Toronto, Canada (GRID:grid.492573.e) (ISNI:0000 0004 6477 6457) 
 New York University School of Medicine, Cryo-Electron Microscopy Core, New York, USA (GRID:grid.137628.9) (ISNI:0000 0004 1936 8753) 
 Sunnybrook Health Sciences Center, Toronto, Canada (GRID:grid.413104.3) (ISNI:0000 0000 9743 1587) 
10  Sinai Health System, Lunenfeld-Tanenbaum Research Institute, Toronto, Canada (GRID:grid.492573.e) (ISNI:0000 0004 6477 6457); University of Toronto, Department of Molecular Genetics, Toronto, Canada (GRID:grid.17063.33) (ISNI:0000 0001 2157 2938) 
11  University of Toronto, Department of Biochemistry, Toronto, Canada (GRID:grid.17063.33) (ISNI:0000 0001 2157 2938); Sinai Health System, Lunenfeld-Tanenbaum Research Institute, Toronto, Canada (GRID:grid.492573.e) (ISNI:0000 0004 6477 6457); University of Toronto, Department of Molecular Genetics, Toronto, Canada (GRID:grid.17063.33) (ISNI:0000 0001 2157 2938) 
Pages
7541
Publication year
2024
Publication date
2024
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3098954327
Copyright
© The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.